RAY's AI-Based Dental Software ‘RAYDENT SW’ Receives FDA Approval
RAY announced that its AI-based software ‘RAYDENT SW’ has received approval from the U.S. Food and Drug Administration (FDA), validating its AI technology in the global market.
RAY’s ‘RAYDENT SW’ is an AI-based software platform designed to digitalize dental care and maximize efficiency. The software suite includes:
RAYFace Analyzer: Creates a 3D virtual patient using advanced scanning technology.
RAYFace Designer: Provides optimal smile guidelines and predicts post-treatment appearance.
Ortho Simulator: Offers visual orthodontic treatment simulations.
Smart Orth: Designs orthodontic appliances and plans treatments.
RAYDENT Designer: An AI-based CAD software for easy and fast prosthesis creation.
SmartCheck: A cloud-based tool for simulation and prosthesis results review and communication.
CEO Sangchul Lee stated, “This FDA approval marks a significant milestone for RAY, strengthening our competitiveness in the global market. ‘RAYDENT SW’ will solidify RAY’s position as a leader in digital dental solutions.”
RAY, known for its innovative digital dental solutions, expects to accelerate sales both domestically and internationally following this FDA certification.
